Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study

Colorectal cancer is a major health problem, and it is the third most diagnosed cancer in the United States. The current treatment for colorectal cancer includes irinotecan, a topoisomerase I inhibitor, and other targeted drugs, such as bevacizumab and regorafenib. The low response rates and inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Narayanan, Silpa, Teng, Qiu-Xu, Wu, Zhuo-Xun, Nazim, Urooj, Karadkhelkar, Nishant, Acharekar, Nikita, Yoganathan, Sabesan, Mansoor, Najia, Ping, Feng-Feng, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386487/
https://www.ncbi.nlm.nih.gov/pubmed/35992866
http://dx.doi.org/10.3389/fonc.2022.949868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386487/
https://www.ncbi.nlm.nih.gov/pubmed/35992866
http://dx.doi.org/10.3389/fonc.2022.949868

Ejemplares similares